Arena's Lorcaserin Expected To Be Approved
Posted on June 18, 2012 at 17:25 PM EDT
According to TheStreet's FDA Drug Approval Contest, Arena Pharmaceuticals Inc.'s (Nasdaq: ARNA) Lorcaserin is expected to receive regulatory approval on June 27. Shares of the biopharmaceutical climbed 98 cents to close at $9.38.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here